PT  - JOURNAL ARTICLE
AU  - Wan Yang
AU  - Jaimie Shaff
AU  - Jeffrey Shaman
TI  - Effectiveness of Non-pharmaceutical Interventions to Contain COVID-19: A Case Study of the 2020 Spring Pandemic Wave in New York City
AID  - 10.1101/2020.09.08.20190710
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.09.08.20190710
4099  - http://medrxiv.org/content/early/2020/12/27/2020.09.08.20190710.short
4100  - http://medrxiv.org/content/early/2020/12/27/2020.09.08.20190710.full
AB  - As COVID-19 continues to pose significant public health threats, quantifying the effectiveness of different public health interventions is crucial to inform intervention strategies. Using detailed epidemiological and mobility data available for New York City and comprehensive modeling accounting for under-detection, we reconstruct the COVID-19 transmission dynamics therein during the 2020 spring pandemic wave and estimate the effectiveness of two major non-pharmaceutical interventions—lockdown-like measures that reducing contact rates and universal masking. Lockdown-like measures were associated with >50% transmission reduction for all age groups. Universal masking was associated with a ∼7% transmission reduction overall and up to 20% reduction for 65+ year-olds during the first month of implementation. This result suggests that face covering can substantially reduce transmission when lockdown-like measures are lifted but by itself may be insufficient to control SARS-CoV-2 transmission. Overall, findings support the need to implement multiple interventions simultaneously to effectively mitigate COVID-19 spread before the majority of population can be protected through mass-vaccination.Competing Interest StatementJ Shaman and Columbia University disclose partial ownership of SK Analytics. J Shaman discloses consulting for BNI. Other authors have nothing to disclose.Funding StatementThis study was supported by the National Institute of Allergy and Infectious Diseases (AI145883), the National Science Foundation Rapid Response Research Program (RAPID; 2027369), and the NYC DOHMH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was classified as public health surveillance and exempt from ethical review and informed consent by the Institutional Review Boards of both Columbia University and NYC DOHMH.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe COVID-19 case and mortality data used here are permitted via a data use and nondisclosure agreement with the NYC DOHMH. Part of the data are publicly available at https://github.com/nychealth/coronavirus-data. For full access, please contact the NYC DOHMH. https://github.com/nychealth/coronavirus-data